Site icon OncologyTube

How Gilteritinib Fits Into Treatment Algorithms For AML

Keith Pratz, MD Assistant Professor of Oncology, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, discusses How Gilteritinib Fits Into Treatment Algorithms For AML. At The 60th ASH Annual Meeting on Dec 1, 2018. http://obroncology.com

Exit mobile version